Speeches: Lipid nanoparticle technology: Paving the way for RNA therapeutics + Lipid nanoparticles: The role of excipients in nucleic acid therapies

Description

Watch Dominik Witzigmann’s and Tomaž Einfalt’s presentations from the ExciPerience 2021 here! (36 minutes)

Recently approved RNA therapeutics, including the first-ever siRNA drug and COVID-19 mRNA vaccines, demonstrate that lipid nanoparticle (LNP) technology is poised to revolutionize drug development. This talk will focus on the current status and future prospects of gene therapies utilizing LNP systems to silence, express or edit genes.

---

The Exciperience covered all areas from basic or advanced research and formulation to manufacturing and regulatory. It was the intersection between all the different perspectives and people in the excipient community.